DOCSLIB.ORG

The Histamine H3 Receptor: Structure, Pharmacology, and Function

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Histamine H3 Receptor: Structure, Pharmacology, and Function 1521-0111/90/5/649–673$25.00 http://dx.doi.org/10.1124/mol.116.104752 MOLECULAR PHARMACOLOGY Mol Pharmacol 90:649–673, November 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW—A LATIN AMERICAN PERSPECTIVE ON G PROTEIN-COUPLED RECEPTORS The Histamine H3 Receptor: Structure, Pharmacology, and Function Gustavo Nieto-Alamilla, Ricardo Márquez-Gómez, Ana-Maricela García-Gálvez, Guadalupe-Elide Morales-Figueroa, and José-Antonio Arias-Montaño Downloaded from Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados (Cinvestav-IPN), Zacatenco, Ciudad de México, México Received April 15, 2016; accepted August 24, 2016 ABSTRACT molpharm.aspetjournals.org Among the four G protein–coupled receptors (H1–H4)identified characteristics of the H3R, namely, its structure, constitutive as mediators of the biologic effects of histamine, the H3 activity, isoforms, signal transduction pathways, regional dif- receptor (H3R) is distinguished for its almost exclusive expres- ferences in expression and localization, selective agonists, sion in the nervous system and the large variety of isoforms antagonists and inverse agonists, dimerization with other generated by alternative splicing of the corresponding mRNA. neurotransmitter receptors, and the main presynaptic and post- Additionally, it exhibits dual functionality as autoreceptor and synaptic effects resulting from its activation. The H3Rhas heteroreceptor, and this enables H3Rs to modulate the hista- attracted interest as a potential drug target for the treatment of minergic and other neurotransmitter systems. The cloning of the several important neurologic and psychiatric disorders, such H3R cDNA in 1999 by Lovenberg et al. allowed for detailed as Alzheimer and Parkinson diseases, Gilles de la Tourette studies of its molecular aspects. In this work, we review the syndrome, and addiction. at ASPET Journals on September 26, 2021 Introduction morphologic characterization of histamine-producing neurons proved the existence of a histaminergic system in the mam- In 1910, Sir Henry Dale and colleagues (Dale and Laidlaw, malian brain (Fig. 1). 1910) isolated histamine from ergot and later found that it had a stimulant effect on smooth muscle from the gut and the respiratory tract, caused vasodepression, stimulated cardiac The Brain Histaminergic System contractility, and induced a shock-like syndrome when in- Histamine-synthesizing neurons are located in the hypo- jected into animals. In 1920, Popielski demonstrated that thalamus tuberomamillary nucleus (TMN), with ∼4500 neu- histamine stimulated gastric acid secretion, and in 1927, the rons found in the rat TMN and ∼64,000 neurons in the human amine was isolated from the liver and the lung, evidencing TMN. These neurons send diffuse projections to the entire that it was a natural constituent of the body (reviewed by central nervous system (CNS) through three major path- Parsons and Ganellin, 2006). ways, two ascending bundles that innervate the forebrain Although histamine was detected in the brain in 1919 by structures and one descending bundle reaching the spinal John J. Abel, its role as a neuromodulator became evident only cord (Watanabe et al., 1984; Airaksinen and Panula, 1988; several decades later; using antibodies against the amine and Haas et al., 2008). its synthesizing enzyme, histidine decarboxylase (HDC), the Histaminergic neurons have a resting membrane potential of about 250 mV and spontaneously fire action potentials at ’ Research in J.-A. A.-M. s laboratory is supported by Cinvestav and the 2.1 6 0.6 Hz with a marked circadian rhythmicity, that is, Mexican Council for Science and Technology (Conacyt). 1 dx.doi.org/10.1124/mol.116.104752. more active during wakefulness. A noninactivating Na ABBREVIATIONS: aa, amino acids; A2AR, adenosine A2A receptor; ACh, acetylcholine; AD, Alzheimer’s disease; CHO, Chinese hamster ovary; CNS, central nervous system; CT, carboxyl terminus; D1R, dopamine D1 receptor; D2R, dopamine D2 receptor; ECL, extracellular loop; 5-HT, 5-hydroxytriptamine (serotonin); GIRK, G protein–gated inwardly rectifying K1 channel; GPCR, G protein–coupled receptor; GTS, Gilles de la Tourette syndrome; H1R, histamine H1 receptor; H2R, histamine H2 receptor; H3R, histamine H3 receptor; H4R, histamine H4 receptor; HDC, histidine decarboxylase; hH3R, human H3R; ICL, intracellular loop; IP3, inositol-1,4,5-trisphosphate; MAPK, mitogen-activated protein kinase; MCH, melanin-concentrating hormone; MSN, striatal medium-sized spiny neuron; NHE, Na1/H1 exchanger; PD, Parkinson’s disease; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C; PTX, pertussis toxin; RT-PCR, reverse-transcription polymerase chain reaction; SN, substantia nigra; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata; TM, transmembrane; TMN, tuberomammillary nucleus. 649 650 Nieto-Alamilla et al. transporter, although astrocytes take up histamine with low affinity (Km 0.56 mM and 4.0 mM) through the activity of the plasma membrane monoamine transporter and, to a lesser extent, the organic cation transporter 3 (Yoshikawa et al., 2013). Histamine Receptors. The differing potency of antago- nists in blocking histamine action to increase the contraction rate in isolated mouse atria and gastric acid secretion or to induce smooth muscle contraction in isolated guinea pig ileum led to the first classification of histamine receptors into the H1 Fig. 1. The histaminergic system in the rat brain. Histamine-synthesizing and H2 subtypes by Ash and Schild (1966), supported by the neurons are located in the hypothalamus tuberomamillary nucleus, and these neurons send projections to the CNS through three major pathways, subsequent development of selective H2 receptor (H2R) an- two ascending bundles that innervate the forebrain structures, and one tagonists (Parsons and Ganellin, 2006). The bovine H1 re- descending bundle reaching the spinal cord. Thal, thalamus; Str, striatum. ceptor (H1R) and the canine H2R were cloned in 1991 (Gantz et al., 1991; Yamashita et al., 1991), allowing for the classifi- cation of these receptors into the class A, rhodopsin-like, of Downloaded from current, active even at 270 mV, appears responsible for G protein-coupled receptors (GPCRs). H1Rs and H2Rs are spontaneous firing, with low-threshold depolarizing Ca21 expressed in the brain and the former signals primarily currents contributing to the repetitive firing. The action through Gaq/11 proteins, whereas the latter activates mainly 21 potential is broad with a significant contribution from Ca Gas proteins (Panula et al., 2015). currents followed by a pronounced (15–20 mV) after hyperpo- A third receptor (H3R) was pharmacologically identified by larization, which activates a depolarizing cationic current (Ih) Arrang et al. (1983) and cloned in 1999 by Lovenberg et al.; the 1 molpharm.aspetjournals.org and two A-type K currents that delay the return to resting H3R activates Gai/o proteins and is expressed almost exclu- potential. The Ca21 currents mediate dendritic histamine sively by neuronal cells of the CNS and the peripheral nervous release and are the target of the autoreceptor-mediated system (Panula et al., 2015). Soon after, a fourth receptor was negative feedback on action potential firing (Haas and Reiner, cloned by several groups (e.g., Nakamura et al., 2000; Oda 1988; Haas et al., 2008). et al., 2000). The H4Rismainlyexpressedbycellsofthe The behavioral state–dependent activity of the histaminer- immune system and, like the structurally related H3R, gic neurons is influenced by several neuronal, humoral, and activates Gai/o proteins (Panula et al., 2015). paracrine signals, and the activity is regulated mainly by excitatory glutamatergic inputs from the cerebral cortex and The Histamine H Receptor the hypothalamus and by inhibitory GABAergic afferents from 3 at ASPET Journals on September 26, 2021 the hypothalamic ventrolateral preoptic nucleus (Ericson In 1983 Arrang et al. reported that in rat cerebro-cortical et al., 1991; Haas et al., 2008; Panula et al., 2015). slices labeled with [3H]-histidine, the depolarization-evoked, Histamine Synthesis, Release, and Catabolism. His- Ca21-dependent release of [3H]-histamine was reduced by tamine is synthesized from the amino acid (aa) L-histidine by exogenous histamine (IC50 41 nM, maximal inhibition 61%). the enzyme HDC, which is expressed in both the neuronal The effect was insensitive to tetrodotoxin, which prevents the bodies and terminals, and the bioavailability of the precursor generation and propagation of action potentials, mimicked by is the rate-limiting factor. Histamine is stored in vesicles in Na-methylhistamine, and antagonized by impromidine and neuronal cell bodies and axon varicosities by the vesicular burimamide with potencies significantly different from those monoamine transporter 2, VMAT-2 (Merickel and Edwards, reported for H2R blockade. More potent H2R antagonists and 1995) and is released by exocytosis upon the arrival of action selective H1R antagonists also showed low potencies. It was potentials (Haas et al., 2008). The synthesis and release of therefore proposed that autoinhibition of histamine release histamine are regulated by H3 autoreceptors (Arrang et al., was mediated by a novel class of receptor (H3R). In a later 1983, 1987b; Morisset et al., 2000). study (Arrang et al., 1985a), autoinhibition of depolarization- Most histaminergic fibers do not make typical synaptic
Load more

Recommended publications
  • TABLE 1 Studies of Antagonist Activity in Constitutively Active
    TABLE 1 Studies of antagonist activity in constitutively active receptors systems shown to demonstrate inverse agonism for at least one ligand Targets are natural Gs and constitutively active mutants (CAM) of GPCRs. Of 380 antagonists, 85% of the ligands demonstrate inverse agonism. Receptor Neutral Antagonist Inverse Agonist Reference Human β2-adrenergic Dichloroisoproterenol, pindolol, labetolol, timolol, Chidiac et al., 1996; Azzi et alprenolol, propranolol, ICI 118,551, cyanopindolol al., 2001 Turkey erythrocyte β-adrenergic Propranolol, pindolol Gotze et al., 1994 Human β2-adrenergic (CAM) Propranolol Betaxolol, ICI 118,551, sotalol, timolol Samama et al., 1994; Stevens and Milligan, 1998 Human/guinea pig β1-adrenergic Atenolol, propranolol Mewes et al., 1993 Human β1-adrenergic Carvedilol CGP20712A, metoprolol, bisoprolol Engelhardt et al., 2001 Rat α2D-adrenergic Rauwolscine, yohimbine, WB 4101, idazoxan, Tian et al., 1994 phentolamine, Human α2A-adrenergic Napthazoline, Rauwolscine, idazoxan, altipamezole, levomedetomidine, Jansson et al., 1998; Pauwels MPV-2088 (–)RX811059, RX 831003 et al., 2002 Human α2C-adrenergic RX821002, yohimbine Cayla et al., 1999 Human α2D-adrenergic Prazosin McCune et al., 2000 Rat α2-adrenoceptor MK912 RX821002 Murrin et al., 2000 Porcine α2A adrenoceptor (CAM- Idazoxan Rauwolscine, yohimbine, RX821002, MK912, Wade et al., 2001 T373K) phentolamine Human α2A-adrenoceptor (CAM) Dexefaroxan, (+)RX811059, (–)RX811059, RS15385, yohimbine, Pauwels et al., 2000 atipamezole fluparoxan, WB 4101 Hamster α1B-adrenergic
    [Show full text]
  • The Histamine H4 Receptor: a Novel Target for Safe Anti-Inflammatory
    GASTRO ISSN 2377-8369 Open Journal http://dx.doi.org/10.17140/GOJ-1-103 Review The Histamine H4 Receptor: A Novel Target *Corresponding author Maristella Adami, PhD for Safe Anti-inflammatory Drugs? Department of Neuroscience University of Parma Via Volturno 39 43125 Parma Italy * 1 Tel. +39 0521 903943 Maristella Adami and Gabriella Coruzzi Fax: +39 0521 903852 E-mail: [email protected] Department of Neuroscience, University of Parma, Via Volturno 39, 43125 Parma, Italy Volume 1 : Issue 1 1retired Article Ref. #: 1000GOJ1103 Article History Received: May 30th, 2014 ABSTRACT Accepted: June 12th, 2014 th Published: July 16 , 2014 The functional role of histamine H4 receptors (H4Rs) in the Gastrointestinal (GI) tract is reviewed, with particular reference to their involvement in the regulation of gastric mucosal defense and inflammation. 4H Rs have been detected in different cell types of the gut, including Citation immune cells, paracrine cells, endocrine cells and neurons, from different animal species and Adami M, Coruzzi G. The Histamine H4 Receptor: a novel target for safe anti- humans; moreover, H4R expression was reported to be altered in some pathological conditions, inflammatory drugs?. Gastro Open J. such as colitis and cancer. Functional studies have demonstrated protective effects of H4R an- 2014; 1(1): 7-12. doi: 10.17140/GOJ- tagonists in several experimental models of gastric mucosal damage and intestinal inflamma- 1-103 tion, suggesting a potential therapeutic role of drugs targeting this new receptor subtype in GI disorders, such as allergic enteropathy, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS) and cancer. KEYWORDS: Histamine H4 receptor; Stomach; Intestine.
    [Show full text]
  • From Inverse Agonism to 'Paradoxical Pharmacology' Richard A
    International Congress Series 1249 (2003) 27-37 From inverse agonism to 'Paradoxical Pharmacology' Richard A. Bond*, Kenda L.J. Evans, Zsirzsanna Callaerts-Vegh Department of Pharmacological and Pharmaceutical Sciences, University of Houston, 521 Science and Research Bldg 2, 4800 Caltioun, Houston, TX 77204-5037, USA Received 16 April 2003; accepted 16 April 2003 Abstract The constitutive or spontaneous activity of G protein-coupled receptors (GPCRs) and compounds acting as inverse agonists is a recent but well-established phenomenon. Dozens of receptor subtypes for numerous neurotransmitters and hormones have been shown to posses this property. However, do to the apparently low percentage of receptors in the spontaneously active state, the physiologic relevance of these findings remains questionable. The possibility that the reciprocal nature of the effects of agonists and inverse agonists may extend to cellular signaling is discussed, and that this may account for the beneficial effects of certain p-adrenoceptor inverse agonists in the treatment of heart failure. © 2003 Elsevier Science B.V. All rights reserved. Keywords. Inverse agonism; GPCR; Paradoxical pharmacology 1. Brief history of inverse agonism at G protein-coupled receptors For approximately three-quarters of a century, ligands that interacted with G protein- coupled receptors (GPCRs) were classified either as agonists or antagonists. Receptors were thought to exist in a single quiescent state that could only induce cellular signaling upon agonist binding to the receptor to produce an activated state of the receptor. In this model, antagonists had no cellular signaling ability on their own, but did bind to the receptor and prevented agonists from being able to bind and activate the receptor.
    [Show full text]
  • Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
    REVIEW published: 21 February 2017 doi: 10.3389/fncel.2017.00037 Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease Dasiel O. Borroto-Escuela 1,2,3, Jens Carlsson 4, Patricia Ambrogini 2, Manuel Narváez 5, Karolina Wydra 6, Alexander O. Tarakanov 7, Xiang Li 1, Carmelo Millón 5, Luca Ferraro 8, Riccardo Cuppini 2, Sergio Tanganelli 9, Fang Liu 10, Malgorzata Filip 6, Zaida Diaz-Cabiale 5 and Kjell Fuxe 1* 1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden, 2Department of Biomolecular Science, Section of Physiology, University of Urbino, Urbino, Italy, 3Observatorio Cubano de Neurociencias, Grupo Bohío-Estudio, Yaguajay, Cuba, 4Department of Cell and Molecular Biology, Uppsala Biomedical Centre (BMC), Uppsala University, Uppsala, Sweden, 5Facultad de Medicina, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Málaga, Spain, 6Laboratory of Drug Addiction Pharmacology, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland, 7St. Petersburg Institute for Informatics and Automation, Russian Academy of Sciences, Saint Petersburg, Russia, 8Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy, 9Department of Medical Sciences, University of Ferrara, Ferrara, Italy, 10Campbell Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada The introduction of allosteric receptor–receptor interactions in G protein-coupled receptor (GPCR) heteroreceptor complexes of the central nervous system (CNS) gave a new dimension to brain integration and neuropsychopharmacology. The molecular basis Edited by: Hansen Wang, of learning and memory was proposed to be based on the reorganization of the homo- University of Toronto, Canada and heteroreceptor complexes in the postjunctional membrane of synapses.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0221245 A1 Kunin (43) Pub
    US 2010O221245A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0221245 A1 Kunin (43) Pub. Date: Sep. 2, 2010 (54) TOPICAL SKIN CARE COMPOSITION Publication Classification (51) Int. Cl. (76) Inventor: Audrey Kunin, Mission Hills, KS A 6LX 39/395 (2006.01) (US) A6II 3L/235 (2006.01) A638/16 (2006.01) Correspondence Address: (52) U.S. Cl. ......................... 424/133.1: 514/533: 514/12 HUSCH BLACKWELL SANDERS LLP (57) ABSTRACT 4801 Main Street, Suite 1000 - KANSAS CITY, MO 64112 (US) The present invention is directed to a topical skin care com position. The composition has the unique ability to treat acne without drying out the user's skin. In particular, the compo (21) Appl. No.: 12/395,251 sition includes a base, an antibacterial agent, at least one anti-inflammatory agent, and at least one antioxidant. The (22) Filed: Feb. 27, 2009 antibacterial agent may be benzoyl peroxide. US 2010/0221 245 A1 Sep. 2, 2010 TOPCAL SKIN CARE COMPOSITION stay of acne treatment since the 1950s. Skin irritation is the most common side effect of benzoyl peroxide and other anti BACKGROUND OF THE INVENTION biotic usage. Some treatments can be severe and can leave the 0001. The present invention generally relates to composi user's skin excessively dry. Excessive use of some acne prod tions and methods for producing topical skin care. Acne Vul ucts may cause redness, dryness of the face, and can actually garis, or acne, is a common skin disease that is prevalent in lead to more acne. Therefore, it would be beneficial to provide teenagers and young adults.
    [Show full text]
  • Ciproxifan, a Histamine H3 Receptor Antagonist, Reversibly Inhibits Monoamine Oxidase a and B Received: 05 September 2016 S
    www.nature.com/scientificreports OPEN Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B Received: 05 September 2016 S. Hagenow1, A. Stasiak2, R. R. Ramsay3 & H. Stark1 Accepted: 07 December 2016 Ciproxifan is a well-investigated histamine H receptor (H3R) inverse agonist/antagonist, showing Published: 13 January 2017 3 an exclusively high species-specific affinity at rodent compared to human H3R. It is well studied as reference compound for H3R in rodent models for neurological diseases connected with neurotransmitter dysregulation, e.g. attention deficit hyperactivity disorder or Alzheimer’s disease. In a screening for potential monoamine oxidase A and B inhibition ciproxifan showed efficacy on both enzyme isoforms. Further characterization of ciproxifan revealed IC50 values in a micromolar concentration range for human and rat monoamine oxidases with slight preference for monoamine oxidase B in both species. The inhibition by ciproxifan was reversible for both human isoforms. Regarding inhibitory potency of ciproxifan on rat brain MAO, these findings should be considered, when using high doses in rat models for neurological diseases. As the H3R and monoamine oxidases are all capable of affecting neurotransmitter modulation in brain, we consider dual targeting ligands as interesting approach for treatment of neurological disorders. Since ciproxifan shows only moderate activity at human targets, further investigations in animals are not of primary interest. On the other hand, it may serve as starting point for the development of dual targeting ligands. Ciproxifan (cyclopropyl 4-(3-(1H-imidazol-4-yl)propyloxy)phenyl methanone) is a well characterized species-specific histamine 3H receptor (H3R) inverse agonist/antagonist (Fig.
    [Show full text]
  • Histamine Receptors
    Tocris Scientific Review Series Tocri-lu-2945 Histamine Receptors Iwan de Esch and Rob Leurs Introduction Leiden/Amsterdam Center for Drug Research (LACDR), Division Histamine is one of the aminergic neurotransmitters and plays of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit an important role in the regulation of several (patho)physiological Amsterdam, De Boelelaan 1083, 1081 HV, Amsterdam, The processes. In the mammalian brain histamine is synthesised in Netherlands restricted populations of neurons that are located in the tuberomammillary nucleus of the posterior hypothalamus.1 Dr. Iwan de Esch is an assistant professor and Prof. Rob Leurs is These neurons project diffusely to most cerebral areas and have full professor and head of the Division of Medicinal Chemistry of been implicated in several brain functions (e.g. sleep/ the Leiden/Amsterdam Center of Drug Research (LACDR), VU wakefulness, hormonal secretion, cardiovascular control, University Amsterdam, The Netherlands. Since the seventies, thermoregulation, food intake, and memory formation).2 In histamine receptor research has been one of the traditional peripheral tissues, histamine is stored in mast cells, eosinophils, themes of the division. Molecular understanding of ligand- basophils, enterochromaffin cells and probably also in some receptor interaction is obtained by combining pharmacology specific neurons. Mast cell histamine plays an important role in (signal transduction, proliferation), molecular biology, receptor the pathogenesis of various allergic conditions. After mast cell modelling and the synthesis and identification of new ligands. degranulation, release of histamine leads to various well-known symptoms of allergic conditions in the skin and the airway system. In 1937, Bovet and Staub discovered compounds that antagonise the effect of histamine on these allergic reactions.3 Ever since, there has been intense research devoted towards finding novel ligands with (anti-) histaminergic activity.
    [Show full text]
  • Title Page CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/ Inverse Agonist with Cognition-Enhan
    JPET Fast Forward. Published on October 14, 2011 as DOI: 10.1124/jpet.111.186585 JPET FastThis articleForward. has not Published been copyedited on and October formatted. 14,The final2011 version as DOI:10.1124/jpet.111.186585 may differ from this version. Title Page CEP-26401 (Irdabisant), a potent and selective histamine H3 receptor antagonist/ inverse agonist with cognition-enhancing and wake promoting activities Downloaded from Rita Raddatz, Robert L. Hudkins, Joanne R. Mathiasen*, John A. Gruner*, Dorothy G. Flood*, Lisa D. Aimone, Siyuan Le*, Hervé Schaffhauser*, Maciej Gasior*, Donna jpet.aspetjournals.org Bozyczko-Coyne, Michael J. Marino*, Mark A. Ator, Edward R. Bacon, John P. Mallamo and Michael Williams* at ASPET Journals on September 24, 2021 Discovery Research Cephalon, Inc. 145 Brandywine Parkway West Chester, PA 19380 USA Copyright 2011 by the American Society for Pharmacology and Experimental Therapeutics. JPET Fast Forward. Published on October 14, 2011 as DOI: 10.1124/jpet.111.186585 This article has not been copyedited and formatted. The final version may differ from this version. JPET #186585 2 Running Title H3 Receptor Antagonist CEP-26401 Corresponding author: Rita Raddatz Cephalon, Inc. 145 Brandywine Parkway West Chester, PA 19380 USA PHONE : (610) 738-6728 FAX: (610) 738-6305 Downloaded from [email protected] Text Pages: 48 Tables: 6 jpet.aspetjournals.org Figures: 7 References: 40 at ASPET Journals on September 24, 2021 Abstract (# of words): 240 Introduction (# of words): 490 Discussion (# of words): 1500 Abbreviations: H3R, histamine H3 receptor; CEP-26401, 6-{4-[3-((R)-2-methyl- pyrrolidin-1-yl)-propoxy]-phenyl}-2H-pyridazin-3-one HCl; ABT-239, 4-(2-{2-[(2R)-2- methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-5-yl)benzonitrile (L) tartrate; RAMH, R-α- methylhistamine; GTPγS, guanosine 5`-(γ-thio)triphosphate; PPI, prepulse inhibition; [3H]NAMH, [3H]N-α-methylhistamine; RID, ratio of investigation duration; DTT, dithiothreitol; EEG, electroencephalographic; EMG, electromyographic; SWS, slow wave sleep; REMS, rapid eye movement sleep.
    [Show full text]
  • Regulation of Ion Channels by Muscarinic Receptors
    Regulation of ion channels by muscarinic receptors David A. Brown Department of Neuroscience, Physiology & Pharmacology, University College London, London, WC1E 6BT (UK). Contact address: Professor D.A.Brown, FRS, Department of Neuroscience, Physiology & Pharmacology, University College London, Gower Street, Londin, WC1E 6BT. E-mail: [email protected] Telephone: (+44) (0)20 7679 7297 Mobile (for urgent messages): (+44)(0)7766-236330 Abstract The excitable behaviour of neurons is determined by the activity of their endogenous membrane ion channels. Since muscarinic receptors are not themselves ion channels, the acute effects of muscarinic receptor stimulation on neuronal function are governed by the effects of the receptors on these endogenous neuronal ion channels. This review considers some principles and factors determining the interaction between subtypes and classes of muscarinic receptors with neuronal ion channels, and summarizes the effects of muscarinic receptor stimulation on a number of different channels, the mechanisms of receptor – channel transduction and their direct consequences for neuronal activity. Ion channels considered include potassium channels (voltage-gated, inward rectifier and calcium activated), voltage-gated calcium channels, cation channels and chloride channels. Key words: Ion channels; neuronal excitation and inhibition; pre- and postsynaptic events; muscarinic receptor subtypes; G proteins; transduction mechanisms. Contents. 1. Introduction: some principles of muscarinic receptor – ion channel coupling. 1.2 Some consequences of the indirect link between receptor and ion channel. + The connection between M1Rs and the M-type K channel as a model system 1.2.1 Dynamics of the response 1.2.2 Sensitivity of the response to agonist stimulation 2. Some muscarinic receptor-modulated neural ion channels.
    [Show full text]
  • Monoaminergic Neuromodulation of Sensory Processing
    fncir-12-00051 July 6, 2018 Time: 17:34 # 1 REVIEW published: 10 July 2018 doi: 10.3389/fncir.2018.00051 Monoaminergic Neuromodulation of Sensory Processing Simon N. Jacob1* and Hendrikje Nienborg2* 1 Department of Neurosurgery, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany, 2 Werner Reichardt Centre for Integrative Neuroscience, University of Tübingen, Tübingen, Germany All neuronal circuits are subject to neuromodulation. Modulatory effects on neuronal processing and resulting behavioral changes are most commonly reported for higher order cognitive brain functions. Comparatively little is known about how neuromodulators shape processing in sensory brain areas that provide the signals for downstream regions to operate on. In this article, we review the current knowledge about how the monoamine neuromodulators serotonin, dopamine and noradrenaline influence the representation of sensory stimuli in the mammalian sensory system. We review the functional organization of the monoaminergic brainstem neuromodulatory systems in relation to their role for sensory processing and summarize recent neurophysiological evidence showing that monoamines have diverse effects on early sensory processing, including changes in gain and in the precision of neuronal responses to sensory inputs. We also highlight the substantial evidence for complementarity between these neuromodulatory systems with different patterns of Edited by: innervation across brain areas and cortical layers as well as distinct neuromodulatory Anita Disney, actions. Studying the effects of neuromodulators at various target sites is a crucial step Vanderbilt University, United States in the development of a mechanistic understanding of neuronal information processing Reviewed by: Summer Sheremata, in the healthy brain and in the generation and maintenance of mental diseases.
    [Show full text]
  • (Gpcrs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on Gpcrs Activated by Neurotransmitters and Inflammation-Associated Molecules
    International Journal of Molecular Sciences Review G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules 1, 2, 2,3 Dragos, -Valentin Predescu y, Sanda Maria Cret, oiu y, Dragos, Cret, oiu , Luciana Alexandra Pavelescu 2, Nicolae Suciu 3,4,5, Beatrice Mihaela Radu 6,7,* and Silviu-Cristian Voinea 8 1 Department of General Surgery, Sf. Maria Clinical Hospital, Carol Davila University of Medicine and Pharmacy, 37-39 Ion Mihalache Blvd., 011172 Bucharest, Romania; [email protected] 2 Department of Cell and Molecular Biology and Histology, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania; [email protected] (S.M.C.); [email protected] (D.C.); [email protected] (L.A.P.) 3 Fetal Medicine Excellence Research Center, Alessandrescu-Rusescu National Institute of Mother and Child Health, Polizu Clinical Hospital, 38-52 Gh. Polizu Street, 020395 Bucharest, Romania; [email protected] 4 Department of Obstetrics and Gynecology, Alessandrescu-Rusescu National Institute of Mother and Child Health, Polizu Clinical Hospital, 38-52 Gh. Polizu Street, 020395 Bucharest, Romania 5 Division of Obstetrics and Gynecology and Neonatology, Carol Davila University of Medicine and Pharmacy, Polizu Clinical Hospital, 38-52 Gh. Polizu Street, 020395 Bucharest, Romania 6 Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independen¸tei,050095 Bucharest, Romania 7 Life, Environmental and Earth Sciences Division, Research Institute of the University of Bucharest (ICUB), University of Bucharest, 91-95 Splaiul Independen¸tei,050095 Bucharest, Romania 8 Department of Surgical Oncology, Prof.
    [Show full text]
  • Update on 3-Iodothyronamine and Its Neurological and Metabolic Actions
    REVIEW ARTICLE published: 16 October 2014 doi: 10.3389/fphys.2014.00402 Update on 3-iodothyronamine and its neurological and metabolic actions Riccardo Zucchi*, Alice Accorroni and Grazia Chiellini Laboratory of Biochemistry, Department of Pathology, University of Pisa, Pisa, Italy Edited by: 3-iodothyronamine (T1AM) is an endogenous amine, that has been detected in many Maria Moreno, University of Sannio, rodent tissues, and in human blood. It has been hypothesized to derive from thyroid Italy hormone metabolism, but this hypothesis still requires validation. T1AM is not a Reviewed by: ligand for nuclear thyroid hormone receptors, but stimulates with nanomolar affinity Anna M. D. Watson, Baker IDI Heart and Diabetes Institute, Australia trace amine-associated receptor 1 (TAAR1), a G protein-coupled membrane receptor. Carolin Stephanie Hoefig, Karolinska With a lower affinity it interacts with alpha2A adrenergic receptors. Additional targets Institutet, Sweden are represented by apolipoprotein B100, mitochondrial ATP synthase, and membrane *Correspondence: monoamine transporters, but the functional relevance of these interactions is still Riccardo Zucchi, Laboratory of uncertain. Among the effects reported after administration of exogenous T1AM to Biochemistry, Department of Pathology, University of Pisa, Via experimental animals, metabolic and neurological responses deserve special attention, Roma 55, 56126 Pisa, Italy because they were obtained at low dosages, which increased endogenous tissue e-mail: [email protected] concentration by about one order of magnitude. Systemic T1AM administration favored fatty acid over glucose catabolism, increased ketogenesis and increased blood glucose. Similar responses were elicited by intracerebral infusion, which inhibited insulin secretion and stimulated glucagon secretion. However, T1AM administration increased ketogenesis and gluconeogenesis also in hepatic cell lines and in perfused liver preparations, providing evidence for a peripheral action, as well.
    [Show full text]